Shandong Sanyuan Biotechnology Co.,Ltd. (SHE:301206)

SHE:301206 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	685.43	324.99	160.29	108.81	489.04	515.72
Short-Term Investments	-	150	2,670	-	-	-
Trading Asset Securities	621.43	123.37	-	-	-	0.33
Cash & Short-Term Investments	1,307	598.35	2,830	108.81	489.04	516.05
Cash Growth	64.27%	-78.86%	2501.17%	-77.75%	-5.23%	129.38%
Accounts Receivable	78.34	85.5	122.37	80.93	51.11	141.36
Other Receivables	2.75	37.55	277.58	6.55	12.82	21.11
Receivables	81.1	123.05	399.95	87.48	63.94	162.47
Inventory	201.82	174.58	142.71	104.33	96.77	112.16
Other Current Assets	97.76	1,268	15.05	21.2	19.62	14.95
Total Current Assets	1,688	2,164	3,388	321.81	669.37	805.62
Property, Plant & Equipment	1,179	1,147	1,047	987.27	952.98	770.61
Long-Term Investments	42.04	42.19	53.18	56.01	60.16	-
Other Intangible Assets	72.62	74.67	46.43	47.58	48.73	49.14
Long-Term Deferred Tax Assets	-	-	-	-	-	2.52
Other Long-Term Assets	1,499	990.67	270.33	3,395	3,139	6.27
Total Assets	4,479	4,419	4,805	4,808	4,870	1,634

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	119.55	95.85	175.7	208.57	184.31	542.47
Accrued Expenses	5.98	8.47	8.65	7.69	9.3	6.71
Current Income Taxes Payable	1.51	-	0	-	-	3.4
Current Unearned Revenue	4.23	11.3	4.82	5.18	4.22	11.43
Other Current Liabilities	102.11	2.37	54.51	2.75	9.68	0.8
Total Current Liabilities	233.39	117.99	243.67	224.2	207.51	564.81
Long-Term Unearned Revenue	1.9	2.44	3.51	4.59	0.86	0.99
Long-Term Deferred Tax Liabilities	54.07	59.29	66.87	43.61	40.78	23.03
Total Liabilities	289.36	179.71	314.04	272.4	249.14	588.83

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	202.33	202.33	202.33	202.33	202.33	101.16
Additional Paid-In Capital	3,518	3,517	3,518	3,518	3,518	72.13
Retained Earnings	530.23	579.83	788.87	815.19	900.84	872.03
Treasury Stock	-60.69	-60.69	-17.6	-	-	-
Comprehensive Income & Other	0.03	0.16	-	-	-	-
Shareholders' Equity	4,190	4,239	4,491	4,535	4,621	1,045
Total Liabilities & Equity	4,479	4,419	4,805	4,808	4,870	1,634

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Net Cash (Debt)	1,307	598.35	2,830	108.81	489.04	516.05
Net Cash Growth	64.27%	-78.86%	2501.17%	-77.75%	-5.23%	129.38%
Net Cash Per Share	6.52	3.01	14.02	0.54	2.45	3.40
Filing Date Shares Outstanding	202.48	200	200.45	202.33	202.33	202.33
Total Common Shares Outstanding	202.48	200	200.45	202.33	202.33	151.74
Working Capital	1,454	2,046	3,144	97.62	461.86	240.81
Book Value Per Share	20.69	21.20	22.41	22.41	22.84	6.89
Tangible Book Value	4,117	4,164	4,445	4,488	4,572	996.19
Tangible Book Value Per Share	20.34	20.82	22.17	22.18	22.60	6.56
Buildings	-	216.25	215.87	172.81	138.83	64.98
Machinery	-	1,067	994.69	864.93	786.97	410.28
Construction In Progress	-	137.18	48.65	103.69	125.13	357.27

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error